Cell-free DNA: Preanalytical variables

Clinica Chimica Acta

Volumn 450, Issue , 2015, Pages 243-253

  Bronkhorst, Abel Jacobus ^a   Aucamp, Janine ^a   Pretorius, Piet J ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Cancer; Cell free DNA; Preanalytical factors; Prenatal diagnostics; Quantitative analysis

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; DNA;

BLOOD SAMPLING; BLOOD STORAGE; CELL FREE SYSTEM; CLINICAL PRACTICE; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; DNA MODIFICATION; HUMAN; HUMAN CELL CULTURE; MEASUREMENT ACCURACY; MOLECULAR MODEL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; BLOOD; BLOOD ANALYSIS; PROCEDURES;

BLOOD CHEMICAL ANALYSIS; CELL-FREE SYSTEM; DNA; HUMANS;

EID: 84941309223     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.08.028     Document Type: Review

References (86)

1. Griffith F. The significance of pneumococcal types. J. Hyg. 1928, 27:113-159.
2. Avery O.T., MacLeod C.M., McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 1944, 79:137-158.
3. Mandel P. Les acides nucleiques du plasma sanguin chez l'homme. CR Acad. Sci. Paris 1948, 142:241-243.
4. Tan E., Schur P., Carr R., Kunkel H. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 1966, 45:1732.
5. Koffler D., Agnello V., Winchester R., Kunkel H.G. The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J. Clin. Invest. 1973, 52:198.
6. Leon S., Shapiro B., Sklaroff D., Yaros M. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977, 37:646-650.
7. Beau-Faller M., Gaub M.P., Schneider A., Ducrocq X., Massard G., Gasser B., Chenard M.P., Kessler R., Anker P., Stroun M. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int. J. Cancer 2003, 105:361-370.
8. Coulet F., Blons H., Cabelguenne A., Lecomte T., Lacourreye O., Brasnu D., Beaune P., Zucman J., Laurent-Puig P. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res. 2000, 60:707-711.
9. Maebo A. Plasma DNA level as a tumor marker in primary lung cancer. Nihon Kyobu Shikkan Gakkai Zasshi 1990, 28:1085-1091.
10. Sozzi G., Conte D., Leon M., Ciricione R., Roz L., Ratcliffe C., Roz E., Cirenei N., Bellomi M., Pelosi G., Pierotti M.A., Pastorino U. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J. Clin. Oncol. 2003, 21:3902-3908.
11. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., Pierotti M.A., Tavecchio L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 2001, 61:4675-4678.
12. Gautschi O., Bigosch C., Huegli B., Jermann M., Marx A., Chasse E., Ratschiller D., Weder W., Joerger M., Betticher D.C., Stahel R.A., Ziegler A. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J. Clin. Oncol. 2004, 22:4157-4164.
13. Paci M., Maramotti S., Bellesia E., Formisano D., Albertazzi L., Ricchetti T., Ferrari G., Annessi V., Lasagni D., Carbonelli C. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009, 64:92-97.
14. Pinzani P., Salvianti F., Zaccara S., Massi D., De Giorgi V., Pazzagli M., Orlando C. Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. Clin. Chim. Acta 2011, 412:2141-2145.
15. Qi J., Qian C., Shi W., Wu X., Jing R., Zhang L., Ju S., Wang Z. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Clin. Biochem. 2012, 46. 10.1016/j.clinbiochem.2012.08.026.
16. Yu M., Wan Y., Zou Q. Cell-free circulating mitochondrial DNA in the serum: a potential non-invasive biomarker for Ewing's sarcoma. Arch. Med. Res. 2012, 43:389-394.
17. Fleischhacker M., Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim. Biophys. Acta 1775, 2007:181-232.
18. Schwarzenbach H., Hoon D.S., Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 2011, 11:426-437.
19. Jung K., Fleischhacker M., Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin. Chim. Acta 2010, 411:1611-1624.
20. Jen J., Wu L., Sidransky D. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann. N. Y. Acad. Sci. 2000, 906:8-12.
21. El Messaoudi S., Rolet F., Mouliere F., Thierry A.R. Circulating cell free DNA: preanalytical considerations. Clin. Chim. Acta 2013, 424:222-230.
22. van der Vaart M., Pretorius P.J. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?. Clin. Biochem. 2010, 43:26-36.
23. Zhong X.Y., Bürk M.R., Troeger C., Kang A., Holzgreve W., Hahn S. Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet. Gynecol. 2000, 96:991-996.
24. Stroun M., Anker P., Maurice P., Lyautey J., Lederrey C., Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989, 46:318-322.
25. de Kok J.B., Hendriks J.C., van Solinge W.W., Willems H.L., Mensink E.J., Swinkels D.W. Use of real-time quantitative PCR to compare DNA isolation methods. Clin. Chem. 1998, 44:2201-2204.
26. Fleischhacker M., Schmidt B., Weickmann S., Fersching D.M., Leszinski G.S., Siegele B., Stötzer O.J., Nagel D., Holdenrieder S. Methods for isolation of cell-free plasma DNA strongly affect DNA yield. Clin. Chim. Acta 2011, 412:2085-2088.
27. Malentacchi F., Pizzamiglio S., Verderio P., Pazzagli M., Orlando C., Ciniselli C.M., Günther K., Gelmini S. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (cfDNA): the SPIDIA-DNAplas external quality assessment experience. Clin. Chem. Lab. Med. 2015, 10.1515/cclm-2014-1161.
28. Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, Wong VW, Wong GL, Chan SL, Mok TS, Chan HL, Lai PB, Chiu RW, Lo YM. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc. Natl. Acad. Sci. U. S. A. 2015; 112: www.pnas.org/cgi/doi/. doi:10.1073/pnas.1500076112.
29. Garcia-Olmo D.C., Dominguez C., Garcia-Arranz M., Anker P., Stroun M., Garcia-Verdugo J.M., Garcia-Olmo D. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res. 2010, 70:560-567.
30. Trejo-Becerril C., Pérez-Cárdenas E., Taja-Chayeb L., Anker P., Herrera-Goepfert R., Medina-Velázquez L.A., Hidalgo-Miranda A., Pérez-Montiel D., Chávez-Blanco A., Cruz-Velázquez J. Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One 2012, 7.
31. Bgahan P. Biology Of Circulating Nucleic Acids And Possible Roles In Diagnosis And Treatment In Diabetes And Cancer. Infectious Disorders-Drug TargetsDisorders 2012, 12:360-370.
32. Swarup V., Rajeswari M. Circulating (cell-free) nucleic acids-a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007, 581:795-799.
33. Jiang N., Pisetsky D.S. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J. Leukoc. Biol. 2005, 77:296-302.
34. Dwivedi D.J., Toltl L.J., Swystun L., Pogue J., Liaw K., Weitz J.I., Cook D.J., Fox-Robichaud A.E., Liaw P.C., Canadian Critical Care Translational Biology Group Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit. Care 2012, 16:R151.
35. Moore D.J., Greystoke A., Butt F., Wurthner J., Growcott J., Hughes A., Dive C. A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients. Clin. Drug Investig. 2012, 32:179-187.
36. Saukkonen K., Lakkisto P., Pettila V., Varpula M., Karlsson S., Ruokonen E., Pulkki K., Finnsepsis Study Group Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin. Chem. 2008, 54:1000-1007.
37. Jylhävä J., Kotipelto T., Raitala A., Jylhä M., Hervonen A., Hurme M. Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: the vitality 90 study. Mech. Ageing Dev. 2011, 132:20-26.
38. Fournie G., Martres F., Pourrat J., Alary C., Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993, 39:215-221.
39. Atamaniuk J., Vidotto C., Tschan H., Bachl N., Stuhlmeier K.M., Müller M.M. Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin. Chem. 2004, 50:1668-1670.
40. Breitbach S., Tug S., Simon P. Circulating cell-free DNA. Sports Med. 2012, 42:565-586.
41. Macher H., Egea-Guerrero J.J., Revuelto-Rey J., Gordillo-Escobar E., Enamorado-Enamorado J., Boza A., Rodriguez A., Molinero P., Guerrero J.M., Dominguez-Roldán J.M. Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clin. Chim. Acta 2012, 24(414):12-17.
42. Sekizawa A., Jimbo M., Saito H., Iwasaki M., Sugito Y., Yukimoto Y., Otsuka J., Okai T. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin. Chem. 2002, 48:353-354.
43. Sekizawa A., Sugito Y., Iwasaki M., Watanabe A., Jimbo M., Hoshi S., Saito H., Okai T. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin. Chem. 2001, 47:2164-2165.
44. Farina A., Sekizawa A., Sugito Y., Iwasaki M., Jimbo M., Saito H., Okai T. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat. Diagn. 2004, 24:83-86.
45. Lo Y., Chan K., Sun H., Chen E.Z., Jiang P., Lun F., Zheng Y.W., Leung T.Y., Lau T.K., Cantor C.R. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl. Med. 2010, 2:61ra91.
46. El Messaoudi S., Thierry A.R. Pre-Analytical Requirements for Analyzing Nucleic Acids from Blood. Circulating Nucleic Acids in Early Diagnosis 2015, 45-69. Springer, Prognosis and Treatment Monitoring, Netherlands. P. Gahan (Ed.).
47. Lee T., Montalvo L., Chrebtow V., Busch M.P. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 2001, 41:276-282.
48. Board R.E., Williams V.S., Knight L., Shaw J., Greystoke A., Ranson M., Dive C., Blackhall F.H., Hughes A. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Ann. N. Y. Acad. Sci. 2008, 1137:98-107.
49. Chan K.C., Yeung S.W., Lui W.B., Rainer T.H., Lo Y.M. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin. Chem. 2005, 51:781-784.
50. Lui Y.Y., Chik K., Chiu R.W., Ho C., Lam C.W., Lo Y.D. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 2002, 48:421-427.
51. Chen Z., Fadiel A., Naftolin F., Eichenbaum K., Xia Y. Circulation DNA: biological implications for cancer metastasis and immunology. Med. Hypotheses 2005, 65:956-961.
52. Harpel P.C., Gordon B.R., Parker T.S. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:3847-3851.
53. Berckmans R.J., Nieuwland R., Boing A., Romijn F., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 2001, 85:639-646.
54. Thierry A.R., Mouliere F., Gongora C., Ollier J., Robert B., Ychou M., Del Rio M., Molina F. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 2010, 38:6159-6175.
55. van Wijk I.J., de Hoon A.C., Jurhawan R., Tjoa M.L., Griffioen S., Mulders M.A., van Vugt J.M., Oudejans C.B. Detection of apoptotic fetal cells in plasma of pregnant women. Clin. Chem. 2000, 46:729-731.
56. Poon L.L., Leung T.N., Lau T.K., Lo Y. Prenatal detection of fetal down's syndrome from maternal plasma. Lancet 2000, 356:1819-1820.
57. Chiu R.W., Poon L.L., Lau T.K., Leung T.N., Wong E.M., Lo Y.M. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin. Chem. 2001, 47:1607-1613.
58. Herrera L.J., Raja S., Gooding W.E., El-Hefnawy T., Kelly L., Luketich J.D., Godfrey T.E. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin. Chem. 2005, 51:113-118.
59. Lam N.Y., Rainer T.H., Chiu R.W., Lo Y.M. EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. Clin. Chem. 2004, 50:256-257.
60. Beutler E., Gelbart T., Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques 1990, 9.
61. Xue X., Teare M.D., Holen I., Zhu Y.M., Woll P.J. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clin. Chim. Acta 2009, 404:100-104.
62. Jung M., Klotzek S., Lewandowski M., Fleischhacker M., Jung K. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin. Chem. 2003, 49:1028-1029.
63. Wu T., Zhang D., Chia J., Tsao K., Sun C., Wu J.T. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin. Chim. Acta 2002, 321:77-87.
64. Sang F., Ren J. Comparisons between capillary zone electrophoresis and real-time PCR for quantification of circulating DNA levels in human sera. J. Chromatogr. B 2006, 838:122-128.
65. Legler T.J., Liu Z., Mavrou A., Finning K., Hromadnikova I., Galbiati S., Meaney C., Hultén M.A., Crea F., Olsson M.L. Workshop report on the extraction of fetal DNA from maternal plasma. Prenat. Diagn. 2007, 27:824-829.
66. Su Y., Wang M., Block T.M., Landt O., Botezatu I., Serdyuk O., Lichtenstein A., Melkonyan H., Tomei L.D., Umansky S. Transrenal DNA as a diagnostic tool: important technical notes. Ann. N. Y. Acad. Sci. 2004, 1022:81-89.
67. Clausen F.B., Krog G.R., Rieneck K., Dziegiel M.H. Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens magnetic extraction system and the QIAamp DSP virus kit in comparison with the QIAamp DNA blood mini kit. Prenat. Diagn. 2007, 27:6-10.
68. Kirsch C., Weickmann S., Schmidt B., Fleischhacker M. An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Ann. N. Y. Acad. Sci. 2008, 1137:135-139.
69. Swinkels D.W., Wiegerinck E., Steegers E.A., de Kok J.B. Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin. Chem. 2003, 49:525-526.
70. Hidestrand M., Stokowski R., Song K., Oliphant A., Deavers J., Goetsch M., Simpson P., Kuhlman R., Ames M., Mitchell M., Tomita-Mitchell A. Influence of temperature during transportation on cell-free DNA analysis. Fetal Diagn. Ther. 2012, 31:122-128.
71. Fernando M., Chen K., Norton S., Krzyzanowski G., Bourne D., Hunsley B., Ryan W., Bassett C. A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. Prenat. Diagn. 2010, 30:418-424.
72. Gaillard C., Strauss F. Eliminating DNA loss and denaturation during storage in plastic microtubes. Am. Clin. Lab. 2001, 20:52-54.
73. Gaillard C., Strauss F. Avoiding Adsorption Of Dna To Polypropylene Tubes And Denaturation Of Short Dna Fragments. Technical Tips Online 1998, 3:63-65.
74. Belotserkovskii B.P., Johnston B.H. Polypropylene tube surfaces may induce denaturation and multimerization of DNA. Science 1996, 271:222-223.
75. Belotserkovskii B.P., Johnston B.H. Denaturation and association of DNA sequences by certain polypropylene surfaces. Anal. Biochem. 1997, 251:251-262.
76. Gaillard C., Strauss F. Association of Poly (CA)-Poly (TG) DNA Fragments into Four-Stranded Complexes Bound by HMG1 and 2. Science-AAAS-Weekly Paper Edition-Including Guide to Scientific Information 1994, 264:433-435.
77. Anchordoquy T.J. Metal contaminants promote degradation of lipid/DNA complexes during lyophilization. Biochim. Biophys. Acta 1768, 2007:669-677.
78. Pedreño E., López-Contreras A.J., Cremades A., Peñafiel R. Protecting or promoting effects of spermine on DNA strand breakage induced by iron or copper ions as a function of metal concentration. J. Inorg. Biochem. 2005, 99:2074-2080.
79. Ahn S.J., Costa J., Emanuel J.R. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res. 1996, 24:2623-2625.
80. Chiminqgi M., Moutereau S., Pernet P., Conti M., Barbu V., Lemant J., Sacko M., Vaubourdolle M., Loric S. Specific real-time PCR vs. flourescent dyes for serum free DNA quantification. Clin. Chem. Lab. Med. 2007, 45:993-995.
81. Powell T.R., Powell-Smith G., Haddley K., McGuffin P., Quinn J., Schalkwyk L.C., Farmer A.E., D'Souza U.M. 2015. Mood-stabilizers differentially affect housekeeping gene expression in human cells. Int. J. Methods Psychiatr. Res. 2015, 23:279-288.
82. Melé M., Ferreira P.G., Reverter F., DeLuca D., Monlong J., Sammeth M., Young T.R., Goldmann J.M., Pervouchine D.D., Sullivan T.J., Johnson R., Segrè A.V., Djebali S., Niarchou A., The GTEx Consortium, Wright F.A., Lappalainen T., Calvo M., Getz G., Dermitzakis E.T., Ardlie K.G., Guigo R. Human transcriptome across tissues and individuals. Science 2015, 348:660-665.
83. Ziegler A., Zangemeister-Wittke U., Stahel R.A. Circulating DNA: a new diagnostic gold mine?. Cancer Treat. Rev. 2002, 28:255-271.
84. Chiu K., Wai R., Dennis Lo Y.M. Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15years of research. Clin. Chem. Lab. Med. 2013, 51:197-204.
85. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141:672-675.
86. Bronkhorst AJ, Aucamp J, Pretorius PJ. Data showing the effect of several preanalytical variables on quantitative measurements of cell-free DNA, (Data in Brief).